Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Inv Regulatory News (IIG)

Share Price Information for Intuitive Inv (IIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 130.00
Bid: 125.00
Ask: 135.00
Change: 0.00 (0.00%)
Spread: 10.00 (8.00%)
Open: 130.00
High: 130.00
Low: 130.00
Prev. Close: 130.00
IIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GM, Tender Offer & Placing & Directorate Change

28 Jul 2023 15:35

RNS Number : 6177H
Intuitive Investments Group plc
28 July 2023
 

Intuitive Investments Group plc

("IIG" or the "Company")

 

General Meeting, Tender Offer and Placing and Directorate Change

New investment policy

Admission to Specialist Fund Segment, and Sir Nigel Rudd to be appointed, Chairman on 8 August

 

Intuitive Investments Group plc (AIM: IIG), a closed-end investment company focussed on the life sciences and technology sectors, announces that at the General Meeting of the Company held at midday today, all resolutions put to Shareholders were duly passed.

 

IIG has received shareholder approval for a number of proposals to support a shift in strategy to invest in a portfolio concentrating on fast growing and / or high potential Life Sciences, Healthcare and Technology businesses operating predominantly in the UK, continental Europe, the US and APAC, targeting an average return to Shareholders of 20 per cent. capital growth per annum. 

 

 The results of the voting are summarised in the table below:

 

Resolution

Description

Votes For

Votes Against

Withheld

One

An ordinary resolution to approve the Company's new investment policy

60,140,450

Nil

Nil

Two

A special resolution for the cancellation of admission of the Ordinary Shares to trading on AIM

60,140,450

Nil

Nil

Three

An ordinary resolution to allot shares in the Company

60,140,450

Nil

Nil

Four

A special resolution to disapply pre-emption rights

60,140,450

Nil

Nil

 

Appointment of Sir Nigel Rudd as Non-Executive Chairman

Sir Nigel Rudd will become the Company's Non-Executive Chairman, subject only to admission of the Company's issued and to be issued Ordinary Shares on the Specialist Fund Segment on 8 August 2023.

 

Result of the Tender Offer

The Company can confirm a total of 62,049 Ordinary Shares have been tendered representing approximately 0.084 per cent. of the Company's issued share capital. Applications under the Tender Offer will be met in full and there will be no scaling back. The total value which will be returned to Shareholders pursuant to the Tender Offer will be approximately £3,258. Payment will be made through CREST for Ordinary Shares purchased pursuant to the Tender Offer on 1 August 2023.

 

The maximum aggregate number of Ordinary Shares that could be purchased by Placees pursuant to the Tender Offer was 12,857,142 Ordinary Shares (representing 17.4 per cent. of the Company's issued share capital) at the Tender Price of 5.25 pence per Ordinary Share, resulting in a maximum amount of £675,000 being returned to Qualifying Shareholders.

 

 

Financing of the Tender Offer

Turner Pope conditionally placed 12,857,142 Ordinary Shares with Placees. Of these 62,049 Ordinary Shares will be used to purchase existing Ordinary Shares validly tendered under the Tender Offer, and the Company will issue 12,795,093 new Ordinary Shares, raising gross proceeds of approximately £671,742 to satisfy the balance of the demand from Placees. The net proceeds will be used to invest in line with the Company's new investment policy and for general working capital purposes.

As disclosed in the Prospectus, Malcolm Gillies and David Evans subscribed for 952,280 Ordinary Shares in the Placing. Their revised shareholdings immediately following Admission are as follows:

Name

Number of Ordinary Shares

Percentage of Share Capital

Malcolm Gillies

1,452,380

1.67%

David Evans

6,552,380

 7.54%

 

Related Party Transaction

Malcolm Gillies is a Director of the Company and his participation in the Placing constitutes a related party transaction in accordance with AIM Rule 13. Robert Naylor, Julian Baines and Colin Willis are not participating in the Placing and are therefore considered independent Directors for these purposes, having consulted with the Company's Nominated Adviser, consider the terms of the Malcolm Gillies' participation in the Placing to be fair and reasonable insofar as Shareholders are concerned.

 

Total voting rights

Application has been made to the London Stock Exchange plc for the admission of the new Ordinary Shares to trading on AIM, which is expected to take effect at 8.00 a.m. on or around 1 August 2023. The new Ordinary Shares will rank equally with the existing Ordinary Shares.

 

Following admission, the Company's issued share capital will consist of 86,859,644 Ordinary Shares. Since the Company currently holds no shares in treasury, the total number of voting rights in the Company will be 86,859,644. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Cancellation and Admission

As previously announced on 11 July 2023, following the approval of the proposed Cancellation by Shareholders at the General Meeting, the last day of dealings in the Company's Ordinary Shares on AIM will be 7 August 2023 and the Cancellation will become effective at 7:00 a.m. on 8 August 2023, subject to a Dealing Notice, as defined in the AIM Rules for Companies, being issued. Admission and dealings in Ordinary Shares on the Specialist Fund Segment will commence at 8:00 a.m. on 8 August 2023.

 

Defined terms used in this announcement shall bear the meaning set out in the Circular dated 11 July 2023.

 

Julian Baines, current non-Executive Chairman, said:

"The Board wish to thank the Company's shareholders for voting overwhelmingly to support a broadening of our investment policy and move to the Specialist Fund Segment of the London Stock Exchange's Main Market. We look forward to updating shareholders on our progress as we pursue exciting opportunities that lie ahead."

 

Intuitive Investments Group plc

www.iigplc.com

Julian Baines, Non-Executive Chairman

Robert Naylor, CEO

Via FTI Consulting

SP Angel Corporate Finance LLP - Nominated Adviser

+44 (0) 20 3470 0470

Jeff Keating / David Hignell / Kasia Brzozowska

Turner Pope Investments (TPI) Ltd - Broker

+44 (0) 20 3657 0050

Andrew Thacker / James Pope

FTI Consulting

Jamie Ricketts / Valerija Cymbal / Jemima Gurney

IIG@fticonsulting.com

 

Dealings by Persons Discharging Managerial Responsibilities

 1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

1) Malcolm Gillies

2) David Evans

2

 

Reason for the notification

 

a)

 

Position/status

1) Non-Executive Director of the Company

2) Chair of the Company's investment committee and founder

b)

 

Initial notification /Amendment

 Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 Intuitive Investments Group plc

b)

 

LEI

 

2138004A32UIY92WWR66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

ISIN: GB00BNGFMW59

b)

Nature of the transaction

 

Subscription for shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1) 952,380

2) 952,380

0.0525p

0.0525p

 

 

 

 

d)

Aggregated information

- Aggregated volume

1,904,760

- Price

0.0525p

e)

Date of the transactions

28 July 2023

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGZNDRFGFZM
Date   Source Headline
8th Apr 20247:00 amRNSIssue and Allotment of Ordinary Shares
22nd Mar 20249:00 amRNSIIG celebrates Sir Nigel Rudd’s award win
21st Mar 20247:00 amRNSIssue and Allotment of Ordinary Shares
7th Mar 20247:00 amRNSHui10 contract win
29th Feb 202410:36 amRNSResult of AGM
28th Feb 20247:00 amRNSIssue of shares
27th Feb 20247:00 amRNSHui10 approved to expand with China Sports Lottery
16th Feb 20247:00 amRNSAppointment of Corporate Broker
6th Feb 202410:45 amRNSPosting of Annual Report and AGM Notice
1st Feb 20242:23 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSFinancial Results
4th Jan 20242:54 pmRNSIssue of shares
29th Dec 20237:00 amRNSTotal Voting Rights
12th Dec 20233:48 pmRNSIssue of shares
28th Nov 20237:00 amRNSUpdate to the Board of Directors
3rd Nov 20231:36 pmRNSDirector Dealing
1st Nov 202310:41 amRNSHolding(s) in Company
27th Oct 20231:33 pmRNSDirector Dealing
27th Oct 20237:00 amRNSInvestment in Hui10 Inc
31st Aug 20238:25 amRNSTotal Voting Rights
10th Aug 202311:08 amRNSHolding(s) in Company
8th Aug 20238:00 amRNSReadmission - Intuitive Investments Group plc
28th Jul 20233:35 pmRNSGM, Tender Offer & Placing & Directorate Change
13th Jul 20235:02 pmRNSForm 8.3 - Yourgene Health PLC - Correction
11th Jul 202310:47 amRNSNotice of General Meeting - Correction
11th Jul 20237:00 amRNSNotice of General Meeting to approve Proposals
11th Jul 20237:00 amRNSIIG appoints Sir Nigel Rudd as its next Chairman
5th Jul 20233:46 pmRNSFORM 8.3 - Yourgene Health Plc
29th Jun 20237:00 amRNSInterim report for the six months to 31 March 2023
31st May 20237:00 amRNSTotal Voting Rights
24th May 20237:00 amRNSReorganisation and Deferred Consideration
26th Apr 20234:57 pmRNSHolding(s) in Company
17th Jan 202311:19 amRNSResult of AGM and Directorate Change
11th Jan 202310:00 amRNSInvestment in Yourgene Health plc
21st Dec 20227:00 amRNSFinal Results
7th Nov 20222:05 pmRNSSecond Price Monitoring Extn
7th Nov 20222:00 pmRNSPrice Monitoring Extension
5th Aug 20227:00 amRNSInvestment in PneumoWave Limited
26th May 20227:00 amRNSUpdate on Sanondaf
25th May 20227:00 amRNSHalf-year Report
20th Apr 202211:13 amRNSDispensation from Rule 9 of the Code
4th Apr 202211:13 amRNSTotal Voting Rights
8th Mar 20223:39 pmRNSHolding(s) in Company
2nd Mar 20227:00 amRNSSubscription
25th Feb 202212:11 pmRNSInvestment & Appointment of Non-Executive Chair
14th Feb 202212:59 pmRNSChange of Registered Office
14th Feb 20227:00 amRNSInvestment in Ocutec Limited
24th Jan 20228:45 amRNSDirector Dealing
30th Dec 202110:58 amRNSResult of AGM
20th Dec 20217:00 amRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.